Results 31 to 40 of about 15,577 (237)

Prescribing azithromycin

open access: yesAustralian Prescriber, 2015
Azithromycin is a broad-spectrum macrolide antibiotic with a long half-life and excellent tissue penetration. It is primarily used for the treatment of respiratory, enteric and genitourinary infections and may be used in preference to other macrolides for some sexually transmitted and enteric infections.
Brendan J, McMullan, Mona, Mostaghim
openaire   +2 more sources

Prevalence of trachoma at sub-district level in Ethiopia : determining when to stop mass azithromycin distribution [PDF]

open access: yes, 2014
To eliminate blinding trachoma, the World Health Organization emphasizes implementing the SAFE strategy, which includes annual mass drug administration (MDA) with azithromycin to the whole population of endemic districts.
Cromwell, Elizabeth A.   +74 more
core   +1 more source

Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study. [PDF]

open access: yes, 2015
BACKGROUND: Mass drug administration (MDA) treatment of active trachoma with antibiotic is recommended to be initiated in any district where the prevalence of trachoma inflammation, follicular (TF) is ≥ 10% in children aged 1-9 years, and then to ...
Jaskiran K. Dhanjal   +73 more
core   +1 more source

Azithromycin consumption during the COVID-19 pandemic in Croatia, 2020.

open access: yesPLoS ONE, 2022
BackgroundDuring the initial phase of the COVID-19 pandemic, there was great enthusiasm for the use of azithromycin with or without hydroxychloroquine.ObjectivesWe analyzed azithromycin consumption in Croatia in 2020 and compared this to the period 2017 ...
Nikolina Bogdanić   +4 more
doaj   +1 more source

Azithromycin Exhibits Activity Against Pseudomonas aeruginosa in Chronic Rat Lung Infection Model

open access: yesFrontiers in Microbiology, 2021
Pseudomonas aeruginosa forms biofilms in the lungs of chronically infected cystic fibrosis patients, which are tolerant to both the treatment of antibiotics and the host immune system.
Manoj Kumar   +11 more
doaj   +1 more source

Mass treatment with azithromycin for trachoma control: participation clusters in households. [PDF]

open access: yes, 2010
BACKGROUND: Mass treatment to trachoma endemic communities is a critical part of the World Health Organization SAFE strategy. However, non-participation may not be at random, affecting coverage surveys and effectiveness if infection is differential ...
Edwards Tansy   +36 more
core   +1 more source

The Concomitant Use of Azithromycin in Clinical Disease Management [PDF]

open access: yesE3S Web of Conferences
Azithromycin, an extensively used second-generation macrolide antibiotic, has been prevalent in the management of a wide range of bacterial infections.
He Xinhang
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Synthetic O‐Polysaccharide Backbone Units for a Single Antigen Vaccine Against Two Major Non‐Typhoidal Salmonella Serovars

open access: yesAngewandte Chemie, EarlyView.
A modular strategy was developed to synthesize tri‐, hexa‐, and nona‐saccharides representing repeating units of the conserved O‐polysaccharide backbone of Salmonella. Conjugates of these glycans to bacteriophage Qβ induced strong IgG responses in mice and rabbits. Antibodies elicited recognized native O‐polysaccharides and conferred protection against
Xingling Pan   +7 more
wiley   +2 more sources

Mass drug administration of antibacterials: weighing the evidence regarding benefits and risks

open access: yesInfectious Diseases of Poverty, 2022
Background Mass drug administration (MDA) is a strategy to improve health at the population level through widespread delivery of medicine in a community.
Robert J. Rolfe   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy